Dr. Wach is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12902 Usf Magnolia Dr
Tampa, FL 33612Phone+1 813-745-2916
Summary
- Dr. Michael Wach is a surgical oncologist based in Tampa, FL, specializing in peritoneal surface malignancies. He graduated from the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo in 2015, where he also completed his surgical residency in 2022. He completed fellowships in Surgical Oncology Research at the National Institutes of Health and in Complex General Surgical Oncology at the University of Pittsburgh. His research has been published in various reputable journals demonstrating a broad spectrum of expertise within his specialty. Dr. Wach's work has been recognized in the academic community, with several of his publications being cited by other scholarly works.
Education & Training
- University at BuffaloResidency, Surgery, 2015
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2015
Certifications & Licensure
- FL State Medical License 2024 - 2026
- VA State Medical License 2016 - 2026
- PA State Medical License 2022 - 2024
- American Board of Surgery Surgery
Publications & Presentations
PubMed
- 2 citationsBreast Surgical Oncology Fellowship applicant selection and ranking: A survey of Society of Surgical Oncology programs.Elizabeth A Hedges, Tahsin M Khan, Martha Teke, Michael M Wach, Jonathan M Hernandez
Journal of Surgical Oncology. 2023-01-01 - 8 citationsAn assessment of perioperative outcomes for open, laparoscopic, and robot-assisted pancreaticoduodenectomy in New York State.Michael M Wach, Ajay A Myneni, Lorin Miller, Joseph Boccardo, Irada Ibrahim-Zada
Journal of Surgical Oncology. 2022-12-01 - 6 citationsRecombinant human Hsp110-gp100 chaperone complex vaccine is nontoxic and induces response in advanced stage melanoma patients.Michael M Wach, John R Subjeck, Xiang-Yang Wang, Elizabeth Repasky, Junko Matsuzaki
Melanoma Research. 2022-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: